VESALIUS-CV

Objective

The purpose of this study is to assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in subjects without a prior MI or stroke at high risk of a cardiovascular event.

View this clinical trail on ClinicalTrials.gov.

Location:

Essentia Health East

Disclosures:

None

For more information about a financial conflict of interest (FCOI), review the Essentia Health FCOI policy.

Last Updated: 01/07/2020

Research Study Categories

  • Adult Studies

Specialty

  • Cardiology
Contact
Cardiology Clinical Trials at 866-839-4128
or clinicaltrials@essentiahealth.org